FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/090015 [Registered on: 02/07/2025] Trial Registered Prospectively
Last Modified On: 01/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Single Arm Study 
Public Title of Study   Understanding Spinal Muscular Atrophy in Children: Insights from a Public Hospital in Western India 
Scientific Title of Study   Clinical profile and diagnostic practices in children with spinal muscular atrophy - a retrospective study at a genetic clinic of a tertiary care public hospital in western India. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Mamta Muranjan 
Designation  Professor 
Affiliation  Seth GS Medical College and KEM Hospital 
Address  Department of Pediatrics, Ward 1, Old KEM Hospital Building, KEM Hospital, Acharya Donde Marg, Parel, Mumbai, Maharashtra

Mumbai
MAHARASHTRA
400012
India 
Phone  02224107647  
Fax    
Email  muranjanmamata@rediffmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vedant Gaikwad 
Designation  Junior Resident 
Affiliation  Seth GS Medical College and KEM Hospital 
Address  Department of Pediatrics, Ward 2, Old KEM Hospital Building, KEM Hospital, Acharya Donde Marg, Parel, Mumbai, Maharashtra

Mumbai
MAHARASHTRA
400012
India 
Phone  8451889411  
Fax    
Email  vedantg1010@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Mamta Muranjan  
Designation  Professor 
Affiliation  Seth GS Medical College and KEM Hospital 
Address  Department of Pediatrics, Ward 1, Old KEM Hospital Building, KEM Hospital, Acharya Donde Marg, Parel, Mumbai, Maharashtra

Mumbai
MAHARASHTRA
400012
India 
Phone  02224107647  
Fax    
Email  muranjanmamta@rediffmail.com  
 
Source of Monetary or Material Support  
nil 
 
Primary Sponsor  
Name  Seth GS Medical College and KEM Hospital 
Address  Seth GS Medical College and KEM Hospital, Acharya Done Marg, Parel, Mumbai 400012 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
nil   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Mamta Muranjan  Seth G.S. Medical College and K.E.M. Hospital   Genetic clinic, Department of Pediatrics, Seth G.S. Medical College and K.E.M. Hospital, Parel, Mumbai 400012 Mumbai Maharashtra
Mumbai
MAHARASHTRA 
02224107647

muranjanmamata@rediffmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, IEC 2, Seth GS Medical College and KEM Hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G129||Spinal muscular atrophy, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  1.00 Day(s)
Age To  18.00 Year(s)
Gender  Both 
Details  All patients of any gender with childhood-onset SMA diagnosed at age less than or equal to 18 years based on genetic testing documenting biallelic deletion of exon 7 ± deletion of exon 8 or compound heterozygous disease-causing variants in the SMN1 gene. 
 
ExclusionCriteria 
Details  1. Adult-onset SMA.
2. SMA caused by genes other than SMN1. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Enhanced understanding of SMA in our patient population: Compilation of comprehensive demographic and clinical data from the SMA patient cohort at our centre will provide valuable insights into prevalent disease subtypes, delays in referral and diagnosis, and highlight atypical presentations or complications.  Single time point study at baseline.  
 
Secondary Outcome  
Outcome  TimePoints 
This study will identify errors in diagnostic practices prevalent in SMA & awareness of misdiagnosis with reference to genetic tests like MLPA, PCR, etc, especially in institutions lacking standardized protocols or access to genetic testing.  1year 
Investigate obstacles to effective treatment, including lack of patient awareness, affordability issues, and limited access to therapies, and thereby identify avenues for improvement in care delivery.   
 
Target Sample Size   Total Sample Size="55"
Sample Size from India="55" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   14/07/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
This retrospective study aims to evaluate the clinical profiles, diagnostic pathways, treatment modalities, and referral patterns of children with Spinal Muscular Atrophy (SMA) who have availed services at the Genetic Clinic of the Department of Paediatrics, Seth GS Medical College and KEM Hospital, Mumbai.
The primary objective is to assess the clinical profile and diagnostic practices of SMA at a genetic clinic of a tertiary care public hospital. Secondary objectives focuses on the management strategies opted and barriers faced by SMA patients in timely diagnosis. Data collection will involve demographics, clinical features, diagnostic and treatment details, and patient outcomes. Key metrics include the time lag from symptom onset to diagnosis, factors contributing to delays, and differences in practices across SMA subtypes. Reasons for delayed presentation, including resource limitations, misinterpretation of symptoms, and systemic barriers, will also be examined.
The study is ethically compliant, with data anonymization and confidentiality maintained. A waiver of informed consent will be sought as the study is retrospective and non-interventional. Statistical analyses will involve descriptive and inferential methods, using SPSS software.
The findings are expected to provide insights into the challenges of diagnosing and managing SMA in India. By identifying gaps in early detection and treatment access, the study aims to inform strategies for improving care timeliness, resource allocation, and awareness among healthcare providers and families. Ultimately, the research seeks to enhance the quality of life for children with SMA by promoting better diagnostic and therapeutic practices within the Indian healthcare framework.
 
Close